Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Sleep Study Market Size & Growth Forecast 2027–2036, By Segments (Testing Services, End-user, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 20643| Published Date: Jun-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Sleep Study Market size was over USD 8.76 Billion in 2026 and is likely to grow at 12.79% CAGR between 2027 and 2036, reaching USD 29.19 Billion by 2036. The industry revenue for 2027 is assessed at USD 9.73 Billion.

Base Year Value (2026)
USD 8.76 Billion
CAGR (2027-2036)
12.79%
Forecast Year Value (2036)
USD 29.19 Billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Sleep Study Market Intelligence Snapshot

Regional Market Dynamics

  • North America accounted for 44.63% in 2026, supported by advanced healthcare infrastructure, specialized sleep centers, diagnostic access, and growing recognition of sleep-related disorders.
  • Asia Pacific is expanding through improving healthcare infrastructure, rising awareness, hospital network development, greater healthcare spending, and wider access to digital and home-based diagnostics.

Segment Momentum

  • In-lab testing captured 81.24% of the market in 2026 because it delivers comprehensive physiological monitoring, accurate diagnosis of complex sleep disorders, and expert clinical supervision for personalized treatment planning.
  • Home care settings are the fastest-growing end-user segment as advanced home monitoring technologies improve patient convenience, support remote diagnostics, and align with growing demand for decentralized healthcare services.

Market Expansion Drivers

  • Rising prevalence of sleep disorders increasing demand for diagnostic sleep testing services
  • Expansion of home-based sleep testing and telemedicine improving patient accessibility
  • Advancements in wearable sleep monitoring devices enhancing remote diagnostic capabilities

Leading Market Participants

  • Key companies in the sleep study market include Koninklijke Philips N.V. (Netherlands), ResMed Inc. (USA), Cleveland Clinic (USA), MedStar Health (USA), Circle Health Group (United Kingdom), Imperial College Healthcare NHS Trust (United Kingdom), Mayo Clinic (USA), SleepMedSite (USA), Midwest Sleep Services Inc. (USA), USA Sleep Diagnostic (USA)

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 8.76 Billion
  • 2027 Estimated Market Size: USD 9.73 Billion
  • Projected Market Size: USD 29.19 Billion by 2036
  • Growth Forecast: 12.79% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: In-Lab Testing (Testing Services) | Hospitals (End-user) | Obstructive Sleep Apnea (Indication)
  • Emerging Opportunity Segment: Home Sleep Testing (Testing Services) | Home Care Settings (End-user) | Insomnia (Indication)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising prevalence of sleep disorders increasing demand for diagnostic sleep testing services

Growing awareness of conditions such as obstructive sleep apnea, insomnia, restless leg syndrome, and other sleep-related disorders is encouraging more individuals to undergo clinical evaluation. The sleep study market growth is driven by healthcare providers placing greater emphasis on early diagnosis to prevent complications associated with untreated sleep disorders and improve long-term patient outcomes. Increased physician referrals, broader public awareness, and expanding recognition of the relationship between sleep quality and overall health are contributing to higher utilization of diagnostic sleep assessment services.

Expansion of home-based sleep testing and telemedicine improving patient accessibility

Healthcare systems are increasingly adopting remote diagnostic pathways that reduce the need for overnight laboratory visits while making sleep assessments more convenient for patients. This shift will propel the sleep study market growth by enabling clinicians to evaluate eligible patients through home-based testing supported by telemedicine consultations and digital data transmission. These approaches improve access for individuals in underserved locations, reduce scheduling barriers, and support more efficient clinical workflows without compromising diagnostic continuity.

Advancements in wearable sleep monitoring devices enhancing remote diagnostic capabilities

Continuous innovation in wearable health technologies is enabling more comprehensive monitoring of sleep patterns outside traditional clinical settings. Within the sleep study market, advanced wearable devices capture physiological indicators such as movement, heart rate, respiratory activity, and sleep stages, providing clinicians with valuable longitudinal data to support diagnostic assessments. Improved sensor accuracy, wireless connectivity, and integration with digital health platforms allow healthcare professionals to review patient information remotely while facilitating ongoing monitoring of treatment effectiveness and sleep health trends.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of sleep disorders increasing demand for diagnostic sleep testing services 2% High North America, Europe High Near Term
Expansion of home-based sleep testing and telemedicine improving patient accessibility 1.8% High North America, Asia Pacific High Near Term
Advancements in wearable sleep monitoring devices enhancing remote diagnostic capabilities 1.6% Moderate Asia Pacific, Europe High Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Sleep Study Market
Largest Region
North America
44.63% Market Share in 2026

North America (Largest Region)

North America held the largest share of the sleep study market, accounting for 44.63% in 2026, supported by advanced healthcare infrastructure, broad availability of diagnostic services, and growing recognition of sleep-related disorders. Increasing awareness of conditions such as sleep apnea and insomnia is encouraging patients to seek professional evaluation and diagnostic testing. The region's established network of hospitals, specialized sleep centers, and healthcare providers also facilitates access to polysomnography and other sleep assessment technologies. In addition, continued adoption of technologically advanced diagnostic systems and greater emphasis on identifying sleep disorders as part of comprehensive healthcare are supporting regional market development.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is anticipated to record the fastest growth, driven by improving healthcare infrastructure, rising awareness of sleep disorders, and increasing access to specialized diagnostic services. Urbanization and changing lifestyles are contributing to greater recognition of sleep-related health concerns, encouraging patients and healthcare professionals to pursue diagnostic evaluation. Expanding hospital networks and investments in modern medical technologies are improving the availability of sleep testing services across emerging economies. Moreover, growing healthcare expenditure and increasing adoption of digital and home-based diagnostic approaches are expected to broaden access to sleep studies and support market expansion throughout the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

United States 🇺🇸

Digital Sleep Diagnostics

The U.S. expands sleep study services by combining home-based diagnostic devices with specialized sleep centers. Healthcare providers increasingly integrate digital monitoring and data analytics to improve patient access and streamline diagnosis of sleep disorders.

Germany 🇩🇪

Clinical Diagnostic Excellence

Germany emphasizes standardized sleep study procedures within hospital sleep laboratories and accredited diagnostic centers. German healthcare providers continue adopting advanced monitoring technologies to support accurate diagnosis and long-term management of complex sleep disorders.

Japan 🇯🇵

Aging Population Assessment

Japan prioritizes sleep study services that address age-related sleep disorders and associated chronic health conditions. Healthcare institutions expand diagnostic capabilities while incorporating compact monitoring technologies suitable for both clinical and home environments.

South Korea 🇰🇷

Connected Sleep Monitoring

South Korea integrates sleep study services with digital health platforms and wearable monitoring technologies. Healthcare providers increasingly use connected diagnostic solutions to improve patient engagement and facilitate earlier identification of sleep-related conditions.

France 🇫🇷

Integrated Care Pathways

France aligns sleep study services with multidisciplinary care for respiratory, neurological, and cardiovascular conditions. French healthcare providers emphasize coordinated diagnostic workflows that improve treatment planning and long-term patient follow-up.

Italy 🇮🇹

Hospital Network Expansion

Italy strengthens sleep study capacity through hospital-based diagnostic units and specialized respiratory clinics. Italian healthcare providers continue modernizing monitoring equipment to improve diagnostic efficiency and broaden access to sleep disorder evaluations.

Segment Analysis

Segment Leadership and Growth Trends

Sleep Study Market Share (%), by Testing Services, 2026

In-Lab Testing
Home sleep testing

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Testing Services Segment Analysis: In-Lab Testing (Largest Segment) vs Home Sleep Testing (Fastest-Growing Segment)

The in-lab testing segment accounted for an 81.24% share of the sleep study market in 2026. In-lab sleep studies remain the preferred diagnostic approach because they provide comprehensive monitoring of multiple physiological parameters under the supervision of trained healthcare professionals. Their ability to deliver highly accurate diagnoses for complex sleep disorders, perform detailed evaluations, and support individualized treatment planning has maintained their leadership across hospitals and specialized sleep centers.

The home sleep testing segment is experiencing the fastest growth as patients increasingly seek convenient and accessible diagnostic options. Portable monitoring devices allow individuals to undergo sleep assessments in familiar home environments, improving patient comfort while reducing the need for overnight clinical visits. Growing awareness of sleep disorders, technological advancements in wearable diagnostic equipment, and expanding acceptance of home-based healthcare are contributing to the rapid adoption of home sleep testing services.

End-user Segment Analysis: Hospitals (Largest Segment) vs Home Care Settings (Fastest-Growing Segment)

The hospitals segment led the sleep study market with a 55.44% share in 2026. Hospitals serve as primary centers for comprehensive sleep disorder diagnosis and treatment, offering access to multidisciplinary specialists, advanced diagnostic equipment, and integrated patient care. Their ability to manage both routine and complex sleep conditions while providing follow-up treatment and monitoring has reinforced their dominant position in the market.

Home care settings are emerging as the fastest-growing end-user segment as healthcare systems increasingly emphasize patient-centered and decentralized care. The availability of advanced home monitoring technologies enables individuals to undergo diagnostic testing without extended hospital visits, improving convenience and accessibility. Rising demand for remote healthcare solutions and greater patient preference for home-based diagnostics continue to accelerate growth in this segment.

Indication Segment Analysis: Obstructive Sleep Apnea (Largest Segment) vs Insomnia (Fastest-Growing Segment)

Holding the largest share of the sleep study market, the obstructive sleep apnea segment accounted for 43.2% in 2026. Obstructive sleep apnea remains the most frequently diagnosed sleep disorder, creating sustained demand for comprehensive sleep assessments and monitoring services. Increasing awareness of the health risks associated with untreated sleep apnea, including cardiovascular complications and reduced quality of life, has encouraged earlier diagnosis and greater utilization of sleep study services.

The insomnia segment is witnessing the fastest growth due to increasing recognition of chronic sleep disturbances and their impact on overall physical and mental well-being. Growing levels of stress, changing lifestyles, and greater awareness of sleep health have encouraged more individuals to seek professional evaluation for persistent sleep difficulties. Enhanced diagnostic approaches and expanding access to specialized sleep care are further supporting the growth of insomnia-related sleep studies.

Segment Sub-Segment Largest Segment Fastest Growing
Testing Services In-lab Testing, Home Sleep Testing In-Lab Testing Home Sleep Testing
End-user Hospitals, Sleep Testing Centers, Home Care Settings Hospitals Home Care Settings
Indication Obstructive Sleep Apnea, Insomnia, Restless Leg Syndrome, Circadian Rhythm Sleeping Disorders, Narcolepsy, Rapid Eye Movement Sleep Disorders, Periodic Limb Movement Disorders, Bruxism Obstructive Sleep Apnea Insomnia
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the sleep study market:

  1. Koninklijke Philips N.V. (Netherlands)
  2. ResMed, Inc. (USA)
  3. Cleveland Clinic (USA)
  4. MedStar Health (USA)
  5. Circle Health Group (United Kingdom)
  6. Imperial College Healthcare NHS Trust (United Kingdom)
  7. Mayo Clinic (USA)
  8. SleepMedSite (USA)
  9. Midwest Sleep Services, Inc. (USA)
  10. USA Sleep Diagnostic (USA)

Providers in the sleep study market are redefining competition by shifting from traditional diagnostic services toward more flexible care models that combine clinical evaluation with technology-enabled monitoring. Healthcare organizations are expanding home-based testing capabilities alongside digital interpretation workflows to improve accessibility while preserving diagnostic quality, prompting laboratories to differentiate through clinical expertise, reporting accuracy, and integrated patient management rather than testing volume alone. The market is also seeing greater emphasis on seamless coordination with broader sleep care pathways, encouraging investment in connected diagnostic platforms and patient engagement tools that enhance continuity across diagnosis, treatment, and long-term follow-up.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Koninklijke Philips N.V. (Netherlands)
ResMed Inc. (USA)
Cleveland Clinic (USA)
MedStar Health (USA)
Circle Health Group (United Kingdom)
Imperial College Healthcare NHS Trust (United Kingdom)
Mayo Clinic (USA)
SleepMedSite (USA)
Midwest Sleep Services Inc. (USA)
USA Sleep Diagnostic (USA)
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Eli Lilly Jun-26 Eli Lilly completed the acquisition of Centessa Pharmaceuticals, integrating clinical-stage orexin receptor 2 agonists into its sleep disorder pipeline. The strategic transaction expands the company's research capabilities targeting narcolepsy and complex sleep-wake disorders.
Nyxoah Jun-26 Nyxoah secured a $15 million investment from the European Investment Bank to accelerate the development, regulatory scaling, and manufacturing readiness of its implantable neurostimulation technologies designed to treat obstructive sleep apnea.
Ozlo Jun-26 Ozlo formed a clinical research partnership with FutureNeuro to evaluate its wearable in-ear sleep technology for managing epilepsy-related sleep disruptions, expanding the technological application of consumer wearables into specialized neurological diagnostics.
Oura Jun-26 Oura expanded its strategic healthcare partnership with Essence Healthcare, launching a targeted clinical monitoring program to identify sleep apnea risks through consumer-facing wearable biometric technology.
BetterNight Sep-25 BetterNight expanded its accredited sleep diagnostic services and healthcare network by executing the dual acquisition of Coastal Sleep Diagnostics and Epoch Sleep Centers, strengthening its competitive positioning in sleep care delivery.
SPARSH Hospitals Sep-25 SPARSH Hospitals launched a new 250-bed super-specialty healthcare facility. The expansion enhances regional market capacity by integrating advanced clinical diagnostic infrastructure, including dedicated sleep study and polysomnography capabilities.
Somnee Jun-25 Somnee completed a $10 million financing round supported by Khosla Ventures and the DeVos family. The capital injection is designated to fund commercial expansion and technical development of the company's wearable sleep technology solutions.
OpenLoop Apr-25 OpenLoop entered into a commercial partnership with Happy Sleep to integrate comprehensive sleep diagnostics into its telehealth platform, establishing a new vertical to capture rising demand for decentralized virtual sleep care.
Onera Health Jan-24 Onera Health secured over €30 million in Series C funding to scale up production and accelerate the global deployment of its patch-based home sleep testing solutions, driving technology adoption in alternative diagnostic settings.
Medical Service Company May-21 Medical Service Company acquired Metz Medical, a provider of sleep and respiratory durable medical equipment. The transaction strategically expanded the acquirer's distribution reach and operational footprint, granting direct access to new payer networks in Wisconsin.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Sleep Study Market — Custom Segments

Segment Sub-Segment
Patient Age Group Pediatric Patients, Adult Patients, Geriatric Patients
Payer Type Private Insurance, Public Insurance, Self-Pay
Referral Source Primary Care Providers, Specialists, Sleep Medicine Specialists, Direct-to-Consumer

Sleep Study Market — Custom TOC

Custom Chapter Custom Details
Home-Based Sleep Diagnostics Adoption Outlook
  • At-Home Diagnostic Modalities and Use-Case Evolution
  • Consumer, Physician and Provider Adoption Drivers
  • Technology Integration Across Connected Sleep Diagnostics
  • Barriers to Home-Based Testing and Care Continuity
  • Commercial Models Supporting Distributed Sleep Diagnostics
Digital Sleep Health Ecosystem Analysis
  • Digital Sleep Monitoring and Diagnostic Ecosystem
  • Integration of Wearables, Apps and Clinical Platforms
  • Data Connectivity and Remote Patient Management Models
  • Provider and Consumer Engagement Pathways
  • Emerging Digital Care Models and Partnership Opportunities
Untapped Patient Population Opportunity Assessment
  • Undiagnosed and Underdiagnosed Sleep Disorder Populations
  • Patient Access Gaps Across Primary and Specialty Care
  • Screening Opportunities in High-Risk Population Groups
  • Patient Activation and Care-Seeking Barriers
  • Priority Opportunity Areas for Market Expansion

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How much is the sleep study market worth?

In 2027 the market for sleep study is valued at USD 9.73 Billion.

What is the expected industry size of sleep study by 2036?

Sleep Study Market size was over USD 8.76 Billion in 2026 and is likely to grow at 12.79% CAGR between 2027 and 2036, reaching USD 29.19 Billion by 2036.

How are greater awareness and early diagnosis priorities influencing sleep study demand?

Increasing recognition of sleep disorders and their broader health implications is encouraging more clinical evaluations. Higher physician referrals and public awareness are supporting greater use of diagnostic sleep assessments to enable earlier intervention and improve long-term patient outcomes.

How are home-based testing and wearable technologies transforming sleep diagnostics?

Remote testing, telemedicine, and connected wearables are making sleep assessments more accessible and convenient. Digital data transmission and continuous physiological monitoring support efficient clinical workflows, remote review, longitudinal analysis, and ongoing evaluation of treatment effectiveness.

Why is in-lab testing the preferred sleep study service?

In-lab testing captured 81.24% of the market in 2026 because it delivers comprehensive physiological monitoring, accurate diagnosis of complex sleep disorders, and expert clinical supervision for personalized treatment planning.

Which end-user segment is expanding the fastest in the sleep study market?

Home care settings are the fastest-growing end-user segment as advanced home monitoring technologies improve patient convenience, support remote diagnostics, and align with growing demand for decentralized healthcare services.

Why did North America hold the largest share of the sleep study market?

North America accounted for 44.63% in 2026, supported by advanced healthcare infrastructure, specialized sleep centers, diagnostic access, and growing recognition of sleep-related disorders.

What is driving faster sleep study market growth in Asia Pacific?

Asia Pacific is expanding through improving healthcare infrastructure, rising awareness, hospital network development, greater healthcare spending, and wider access to digital and home-based diagnostics.

What are the key competitors in the sleep study landscape?

Key companies in the sleep study market include Koninklijke Philips N.V. (Netherlands), ResMed Inc. (USA), Cleveland Clinic (USA), MedStar Health (USA), Circle Health Group (United Kingdom), Imperial College Healthcare NHS Trust (United Kingdom), Mayo Clinic (USA), SleepMedSite (USA), Midwest Sleep Services Inc. (USA), USA Sleep Diagnostic (USA)
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →